Stocks
Amgen's Sjogren's Treatment Shows Promising Results
Amgen has announced success in its research for a treatment of Sjogren's syndrome, a chronic autoimmune disorder. The company reported positive results from a Phase 2 clinical trial of its experimental medication.
The trial demonstrated significant improvements in patients with the condition, showing that Amgen's medication can effectively reduce symptoms and improve quality of life. The exact results of the trial have not been disclosed by the company.